SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TLT.v
TLT.V 0.200-4.8%11:54 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: 3bar5/24/2021 2:05:39 PM
   of 1867
 
Sherrie says if we get good #s from this treatment we commercialize it . This a post by @jayro about 20 th.

It seems she still working in close partnership with Theralase and their relationship still ongoing contrary to what we may have heard on this board in prior months. She clearly stated if phase 2 data is good, we commercialize this treatment. No phase 3 (huge development for our share price once it materializes). She is working on other cancers as we speak. She mentioned (for competition) there is only one PDC authorized for use in cancer treatment.....forgot the name- starts with the letter "P" I think. This bodes well for us when the FDA reviews for safety and efficacy. She continues to work and research with follow scientists including some connected to Theralase. Again, a great deal of science talk which I didn't understand but our drug(s) sound very promising based on her words! She gave a background into discovering the drug and her other company including oral hygiene. After seeing her on the webcast talking up our drug to many and discussing the Therlase partnership.....I'm very optimistic for the potential future value and successful completion of ph2 trial. Great deal of promise with TLT.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext